by PEAK Medicals | 6 November 2024
Antibody Drug Conjugates WELCOME & INTRODUCTION BY HOST Alessandra Curioni EMERGING TRENDS & CLINICAL IMPACT OF ADCs IN GENITOURINARY CANCERS Giuseppe Banna CURRENT AND FUTURE STANDARDS OF ADCs IN BREAST CANCER CARE Paolo Tarantino NEW DEVELOPMENTS IN LUNG CANCER CARE...
by PEAK Medicals | 19 June 2024
GI Cancers (ASCO 2024) Welcome & introduction by host Thibaud Kössler NEW TREATMENT UPDATES IN UPPER GI ELIZABETH SMYTH LATEST INSIGHTS FOR HCC AND PANCREATIC CANCER SARA DE DOSSO HIGHLIGHTED DATA FROM ASCO FOR CRC THIBAUD KÖSSLER  } 1 h 31 min Get Your CME...
by PEAK Medicals | 6 February 2024
Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...
by PEAK Medicals | 24 January 2024
Early NSCLC Welcome & introduction by host Isabelle Opitz Doing more with less: state of the art in tissue acquisition Carolin Steinack Current standards for pathology reporting in lung cancer Lukas Bubendorf Recent advances in thoracic surgery in lung cancer...
by PEAK Medicals | 19 April 2023
HER2 in Breast, Lung & GI Cancers Welcome & general introduction into HER2 testing Sabina Berezowska HER2 as a biomarker in breast cancer Zsuzsanna Varga Treatment considerations for HER2-positive GI-cancers Florian Lordick Clinical implications of HER2 in lung...
